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ASD and schizophrenia show distinct developmental proﬁles
in common genetic overlap with population-based social
communication difﬁculties
B St Pourcain1,2,3,22, EB Robinson4,5,22, V Anttila4,5, BB Sullivan4,5, J Maller4, J Golding6, D Skuse7, S Ring1,2, DM Evans1,8, S Zammit1,9,
SE Fisher3,10, BM Neale4,5,11, RJL Anney11, S Ripke4,5,12, MV Hollegaard13, T Werge14,15,16, iPSYCH-SSI-Broad Autism Group, A Ronald17,
J Grove14,18,19,20, DM Hougaard13, AD Børglum14,18,19, PB Mortensen14,19,21, MJ Daly4,5,23 and G Davey Smith1,2,23
Difﬁculties in social communication are part of the phenotypic overlap between autism spectrum disorders (ASD) and
schizophrenia. Both conditions follow, however, distinct developmental patterns. Symptoms of ASD typically occur during early
childhood, whereas most symptoms characteristic of schizophrenia do not appear before early adulthood. We investigated whether
overlap in common genetic inﬂuences between these clinical conditions and impairments in social communication depends on
the developmental stage of the assessed trait. Social communication difﬁculties were measured in typically-developing youth
(Avon Longitudinal Study of Parents and Children, N⩽ 5553, longitudinal assessments at 8, 11, 14 and 17 years) using the Social
Communication Disorder Checklist. Data on clinical ASD (PGC-ASD: 5305 cases, 5305 pseudo-controls; iPSYCH-ASD: 7783 cases,
11 359 controls) and schizophrenia (PGC-SCZ2: 34 241 cases, 45 604 controls, 1235 trios) were either obtained through the
Psychiatric Genomics Consortium (PGC) or the Danish iPSYCH project. Overlap in genetic inﬂuences between ASD and social
communication difﬁculties during development decreased with age, both in the PGC-ASD and the iPSYCH-ASD sample. Genetic
overlap between schizophrenia and social communication difﬁculties, by contrast, persisted across age, as observed within two
independent PGC-SCZ2 subsamples, and showed an increase in magnitude for traits assessed during later adolescence. ASD- and
schizophrenia-related polygenic effects were unrelated to each other and changes in trait-disorder links reﬂect the heterogeneity of
genetic factors inﬂuencing social communication difﬁculties during childhood versus later adolescence. Thus, both clinical ASD and
schizophrenia share some genetic inﬂuences with impairments in social communication, but reveal distinct developmental proﬁles
in their genetic links, consistent with the onset of clinical symptoms.
Molecular Psychiatry advance online publication, 3 January 2017; doi:10.1038/mp.2016.198
INTRODUCTION
The phenotypic overlap between autism spectrum disorder (ASD)
and schizophrenia is complex and dates back to Kanner in 1943.1
Individuals affected by either condition display deﬁcits in the ability
to initiate and maintain reciprocal interaction.2 This includes
impairments in social cognition3,4 but also poor social
competence5 affecting verbal and nonverbal communication skills.
Recent cross-disorder genetic analyses highlighted the continuity of
psychiatric phenotypes beyond current diagnostic boundaries.6
The nature of shared genetic inﬂuences between childhood
neurodevelopmental disorders, such as ASD, and adult-onset
psychiatric illnesses, like schizophrenia, however, remains less well
understood.
ASD represent a group of neurodevelopmental conditions with
a typical age of onset before the age of 3 years affecting ~ 1 to 2%
of children.7,8 Core features include deﬁcits in social interaction
and communication, as well as highly restricted interests and/or
stereotyped repetitive behaviours.2 By contrast, schizophrenia is
an adult-onset psychiatric illness with a typical ﬁrst-time diagnosis
between 16 and 30 years. The disorder has a lifetime prevalence of
1MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK; 2School of Social and Community Medicine, University of Bristol, Bristol, UK; 3Language and Genetics
Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands; 4Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard
Medical School, Boston, MA, USA; 5Stanley Center for Psychiatric Research and Medical and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard,
Cambridge, MA, USA; 6Centre for Child and Adolescent Health, University of Bristol, Bristol, UK; 7Behavioural and Brain Sciences, Institute of Child Health, University College
London, London, UK; 8University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia; 9MRC Centre for Neuropsychiatric Genetics and
Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK; 10Donders Institute for Brain, Cognition and Behaviour, Radboud
University, Nijmegen, The Netherlands; 11Department of Psychiatry, Harvard Medical School, Boston, MA, USA; 12Department of Psychiatry and Psychotherapy, Charité -
Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany; 13Statens Serum Institut, Department of Congenital Disorders, Copenhagen, Denmark; 14The Lundbeck Foundation
Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark; 15Institute of Biological Psychiatry, MHC Sct. Hans, Mental Health Services Copenhagen, Copenhagen,
Denmark; 16Institute of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Copenhagen, Copenhagen, Denmark; 17Department of Psychological Sciences,
Birkbeck, University of London, London, UK; 18Department of Biomedicine, Aarhus University, Aarhus, Denmark; 19Centre for Integrative Sequencing, iSEQ, Aarhus University,
Aarhus, Denmark; 20Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark and 21National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
Correspondence: Dr B St Pourcain, Language and Genetics Department, Max Planck Institute for Psycholinguistics, Wundtlaan 1, Nijmegen 6525 XD, The Netherlands.
E-mail: Beate.StPourcain@mpi.nl
22These authors contributed equally to this work.
23These authors codirected the study.
Received 15 March 2016; revised 10 June 2016; accepted 1 August 2016
Molecular Psychiatry (2017) 00, 1–8
www.nature.com/mp
~ 1%9 and is characterised by hallucinations, delusions, disorga-
nised speech or behaviour, apathy and lack of emotional
reactivity.2 Both ASD and schizophrenia are highly heritable10,11
and recent studies have linked different types of genetic variation
including common variants,10,12,13 as well as rare inherited14,15
and de novo variation16,17 to risk of illness in both conditions.
Contemporary research strongly supports a genetic overlap
between ASD and schizophrenia for rare copy number variants18
and rare de novo mutation events16 with converging evidence for
gene sets involved in synaptic function.16 The role of shared
common genetic risk between ASD and schizophrenia, however, is
less clear. Common genetic inﬂuences account for 25 to 33%19 of
total liability to schizophrenia and up to 49% of total liability to
ASD.10,12 Despite this, the common genetic overlap between ASD
and schizophrenia is small compared with the overlap between
psychiatric adult-onset only disorders.12,20
The framework of Research Domain Criteria (RDoC), including
social communication difﬁculties, now actively facilitates the study
of functional dimensions spanning the full range of human
behaviour from normal to abnormal and across development.21
Common disorders, due to their polygenic architecture, can be
understood as quantitative traits.22 For ASD, following the ﬁndings
of earlier twin studies,23,24 there is now molecular evidence for
shared common genetic inﬂuences with social communication
difﬁculties during childhood.25 The genetic continuity of social
interaction and communication deﬁcits in schizophrenia has not
yet been observed though it can be hypothesised that such
common genetic links exist given the impairments in social
cognition within ﬁrst-degree relatives of schizophrenia patients.3
Impaired abilities in social communication in affected children
are heritable (twin-h2 = 0.74)26 and a large part of these genetic
inﬂuences can be captured through common single-nucleotide
polymorphisms (SNPs; SNP-h2⩽ 0.45).27 Beside some stable
genetic inﬂuences,28 genetic factors underlying social interaction
impairments and social communication difﬁculties vary during
development,27,28 especially for common variation.27 Thus, we
hypothesise that also the genetic overlap between social
communication difﬁculties and clinically recognised disorder
may change during childhood and adolescence.
The primary aim of this study is to examine the nature of
common polygenic inﬂuences in ASD and schizophrenia through
their genetic overlap with phenotypic symptoms in the general
population that are shared between both conditions, but differ
according to developmental stage. We predict that if social
communication difﬁculties are part of a common shared aetiology
between ASD and schizophrenia, trait-disorder relationships for
both conditions should follow similar patterns. Dissimilar patterns
due to independent genetic inﬂuences would be expected for a
non-shared genetic aetiology. Here, we report developmental
proﬁles in common genetic overlap for both ASD and schizo-
phrenia with respect to longitudinal measures of social commu-
nication difﬁculties within the general population. Analyses are
based on the largest publicly available genome-wide data for
ASD29 and schizophrenia,13 in addition to a large Danish ASD
sample from the iPSYCH project and a deeply-phenotyped UK
birth cohort, the Avon Longitudinal Study of Parents and Children
(ALSPAC).30,31
MATERIALS AND METHODS
Genome-wide summary statistics
Population-based social communication difﬁculties. Genome-wide associa-
tion studies (GWASs) were carried out in ALSPAC participants, a UK
population-based longitudinal pregnancy-ascertained birth cohort (esti-
mated birth date: 1991–1992).30,31 Ethical approval was obtained from the
ALSPAC Law-and-Ethics Committee (IRB00003312) and the Local Research-
Ethics Committees, written informed consent was obtained from a parent
or individual with parental responsibility and assent was obtained from
child participants.
ALSPAC children were genotyped using the Illumina HumanHap550
quad-chip and imputation was performed on 8237 children and 477,482
SNP genotypes using a 1000 Genomes reference (PhaseI_v3, http://www.
1000genomes.org/)32 (Supplementary Methods).
Quantitative social communication problems in ALSPAC children were
assessed with the 12-item Social Communication Disorder Checklist (SCDC;
score-range: 0 to 24).26 The SCDC is a brief screening instrument of social
reciprocity and verbal/nonverbal communication (for example, ‘Not aware
of other people’s feelings’), with high reliability and good validity,26 which
has been extensively investigated.26,27,33 Higher SCDC scores reﬂect more
social communication deﬁcits and are positively skewed (Supplementary
Figure 1). Mother-reported scores for children and adolescents were
repeatedly measured at 8, 11, 14 and 17 years (Supplementary Table 1) and
are inter-correlated (Spearman's ρ: 0.39 to 0.57, Supplementary Table 2).
Information on phenotypic and genotypic data was available for 4175 to
5553 children (Table 1).
SCDC scores were residualised for sex, age and the two most signiﬁcant
ancestry-informative principal components34 and then rank-transformed
(Supplementary Figure 2). Transformed scores showed similar correlation
patterns as untransformed scores (Pearson' r: 0.38 to 0.61, Supplementary
Table 2).
Genome-wide single marker summary statistics were generated by
regressing rank-transformed residuals on allele dosages using SNPTEST35
(without genomic control-based correction36).
Clinical ASD. The Psychiatric Genomics Consortium (PGC) has completed
a genome-wide scan of 5305 ASD cases and their parents (PGC-ASD), all of
European ancestry (2015 freeze; summary results at http://www.med.unc.
edu/pgc/). An ASD diagnosis was conﬁrmed using research standard
diagnoses and expert clinical consensus diagnoses. 94.1% of all ASD cases
had also a diagnosis of autism from the Autism Diagnostic Interview-
Revised37 and/or the Autism Diagnostic Observation Schedule.38 Genome-
wide data were imputed to a 1000 Genomes reference (PhaseI_v3) and
genetic association studied using a case and pseudo-control design.29 This
design is robust to population stratiﬁcation as pseudo-controls are based
on un-transmitted parental alleles, and thus cases and pseudo-controls are
ancestrally matched. To replicate ﬁndings, we analysed ASD GWAS
summary results in the Danish iPSYCH project (iPSYCH-ASD: 7783 ASD
cases, 11 359 controls) using samples from the Danish Neonatal Screening
Biobank hosted by Statens Serum Institute (Supplementary Methods). The
iPSYCH-ASD project aims to genotype all Danish individuals with available
DNA from bloodspots and an ASD diagnosis (International Classiﬁcation of
Diseases39) in their medical record. iPSYCH-ASD has been genotyped using
the Illumina Inﬁnium PsychArray BeadChip and genotypes were imputed
to a 1000 Genomes template (PhaseI_v3). This study has been approved by
the Danish research ethical committee system.
Note that also a small number of ALSPAC children with clinical ASD (N⩽
36) has been included in this study (Supplementary Methods).
Clinical schizophrenia. A large PGC mega-analysis on schizophrenia has
been carried out studying individuals of predominantly European
descent13 (Summary results at http://www.med.unc.edu/pgc/). Cases met
diagnostic criteria for either schizophrenia or schizoaffective disorder.13
Here, we investigated two non-overlapping schizophrenia subsets: (1) PGC-
SCZ1 (11 958 cases, 12 710 controls), constructed as part of the ﬁrst PGC
mega-analysis of schizophrenia,13,40 and (2) PGC-SCZ2i, containing novel
PGC-SCZ2 cases and controls not included in PGC-SCZ1 (22 283 cases,
32 894 controls, 1235 trios).13 In addition, we studied the combined PGC-
SCZ2 sample (PGC-SCZ1+PGC-SCZ2i: 34 241 cases, 45 604 controls, 1235
trios) of the second PGC mega-analysis of schizophrenia.13 As PGC-SCZ2
contains 1836 cases and 3383 controls from East Asia, we also studied a
PGC-SCZ2 sample of European ancestry only (PGC-SCZ2-Eur: 32 405 cases,
42 221 controls, 1235 trios). Genome-wide data were imputed to a 1000
Genomes template (PhaseI_v3).
The studied population-based and clinical samples (Table 1) contain no
sample overlap.
Other adult-onset disorders. To analyse the speciﬁcity of genetic overlap
between SCDC scores and schizophrenia, we studied further adult-onset
psychiatric disorders, such as major depressive disorder (MDD) and bipolar
disorder (BIP; Supplementary Methods).
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Statistical methods
Linkage disequilibrium (LD) score regression41 was applied to estimate the
cumulative effect of common SNPs on either variation in developmental
SCDC scores or risk to disorder (SNP-h2), using GWAS statistics and
exploiting LD patterns in the genome. LD score correlation20 analysis was
carried out to estimate genetic correlations (rg) between SCDC scores and
clinical conditions, or among clinical conditions, that is, the extent to which
two phenotypes share common genetic factors, based on GWAS statistics.
All analyses were performed with LDSC software20,41 using HapMap3
markers42 (Supplementary Methods).
Polygenic risk scores (PGS)43,44 were analysed to estimate the explained
phenotypic variance in social communication difﬁculties due to risk-
increasing alleles for clinical disorder. Using a range of P-value thresholds
(0.001oPT⩽ 1), PGS for ASD (based on PGC-ASD), schizophrenia (based
on PGC-SCZ2) and schizophrenia subsamples (based on PGC-SCZ1 and
PGC-SCZ2i) were generated in ALSPAC (Table 1) using imputed genotypes
(1000 Genomes, PhaseI_v3, INFO40.8). For this, common autosomal
signals observed in clinical samples (with MAF40.01 in ALSPAC) were
clumped (LD-r240.25, ± 500 kb) consistent with current guidelines45 using
PLINK,46 excluding duplicate SNPs (Supplementary Methods). Rank-
transformed SCDC scores were regressed on Z-standardised PGS (Ordinary
least square regression, R software Rv3.2.2, https://cran.r-project.org/), and
the proportion of phenotypic variance explained by each PGS predictor
reported as adjusted regression R2. Note that assuming an inﬁnitely large
clinical 'discovery' sample, the regression R2 is equivalent to the product of
rg squared and the heritability of the explained Z-standardised trait.
44
Mixed Poisson regression (R:lme4 library) was utilised to test the trend in
common genetic overlap longitudinally using untransformed SCDC scores.
Repeatedly assessed SCDC score counts were regressed on ASD- and
schizophrenia-PGS with overdispersion being accounted for through the
random error part.47 Models included ﬁxed effects for ASD-PGS and
schizophrenia-PGS, sex, age at assessment, as well as random intercepts.
Beta-coefﬁcients for PGS quantify here the increase in natural-log SCDC
scores for each increase in one standard deviation of PGS. Differences in
sample-dropout across time were accounted for through bootstrapping,
generating parametric 95%-bootstrap conﬁdence intervals
(NBootstrap = 500). We have not estimated adjusted R
2-related measures
due to the difﬁculty of deﬁning the residual variance for non-Gaussian
responses, especially within a mixed model context.48
Genome-wide Complex Trait Analysis (GCTA)49,50 was utilised to
estimate SNP-h2 and genetic correlations among SCDC scores, as
published previously,27 for comparison only (Supplementary Methods).
Attrition analysis in ALSPAC studied the relationship between SCDC-
missingness at each assessed age and PGS for clinical ASD and
schizophrenia (Supplementary Methods).
RESULTS
SNP-heritabilities for social communication difﬁculties and
psychiatric disorder
Genome-wide analyses of population-based SCDC scores at 8, 11,
14 and 17 years provided little evidence for bias in GWAS statistics
due to population stratiﬁcation. The estimated LDSC-h2 intercepts
were consistent with one, ranging from 0.988 (s.e. = 0.0067) to
1.009 (s.e. = 0.0070; Table 2). In subsequent analyses LDSC-h2
intercepts were thus constrained to one, including LDSC correla-
tion analyses.
Cumulative inﬂuences of SNPs on variation in SCDC scores were
strongest at the age of 8, 11 and 17 years with LDSC-h2 estimates
of 0.19 (s.e. = 0.06), 0.17 (s.e. = 0.07) and 0.30 (s.e. = 0.11), respec-
tively (Table 2). The estimates were lower, however, at 14 years
(LDSC-h2 = 0.08 (s.e. = 0.06)). These LDSC-based ﬁndings mirrored
closely GCTA-h2 estimates using GREML (Table 2), although latter
might potentially be biased.51 SCDC scores shared furthermore
genetic factors across development (GREML rg = 0.38 (s.e. = 0.16)
to 0.95 (s.e. = 0.34), Pmin = 2 × 10
− 7), as previously reported,27 with
lower correlations across wider age gaps (Supplementary Table 3).
A common genetic basis for ASD has been described earlier12,25
including PGC-ASD (liability-scale LDSC-h2 = 0.23 (s.e. = 0.03))25
and iPSYCH-ASD (liability-scale LDSC-h2 = 0.14 (s.e. = 0.03)),25 with
strong evidence for similar polygenic architectures among samples
(rg = 0.74 (s.e. = 0.07), Po10−20).25 Also, it is known12,13,40 thatT
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common genetic factors inﬂuence schizophrenia liability. Liability-
scale LDSC-SNP-h2 estimates for PGC-SCZ1, PGC-SCZ2i, PGC-
SCZ2Eur and PGC-SCZ2 were 0.31 (s.e. = 0.02), 0.24 (s.e. = 0.01),
0.25 (s.e. = 0.01) and 0.25 (s.e. = 0.01), respectively (assumed
population-prevalence of 0.01), with strong evidence for shared
genetic factors among independent samples (PGC-SCZ1 and PGC-
SCZ2i: rg = 0.96 (s.e. = 0.024), Po10−20).
Genetic correlations between social communication difﬁculties
and psychiatric disorder
As part of a two-stage analysis design (Table 1), we used
constrained LD score correlation to study the genetic overlap
between psychiatric disorder and social communication problems
during development. Genetic correlations between rank-
transformed social communication difﬁculties and clinical ASD
decreased in point estimates with progressing age of the trait
(Figure 1a, Supplementary Table 4). For PGC-ASD, the genetic link
with SCDC scores was strongest at 8 years (rg = 0.34 (s.e. = 0.15),
P= 0.027)25 and attenuated by 17 years (rg = 0.01 (s.e. = 0.12),
P= 0.94). This pattern was replicated in iPSYCH-ASD (rg = 0.35
(s.e. = 0.13), P= 0.008 and rg = 0.02 (s.e. = 0.10), P= 0.81, respec-
tively, Supplementary Table 4). In contrast, common genetic links
between schizophrenia and social communication difﬁculties
during childhood and adolescence persisted and increased in
point estimates (Figure 1b). Within PGC-SCZ1, genetic overlap with
SCDC scores started to emerge at 8 years (rg = 0.20 (s.e. = 0.08),
P= 0.01) and was strongest at 17 years (rg = 0.24 (s.e. = 0.08),
P= 0.004; Figure 1b, Supplementary Table 4). The genetic link
during later adolescence was replicated in PGC-SCZ2i (age 17:
rg = 0.15 (s.e. = 0.06), P= 0.011, Figure 1b) and also observed in the
combined PGC-SCZ2 sample (PGC-SCZ1+PGC-SCZ2i: rg = 0.18
(s.e. = 0.06), P=0.003, Supplementary Table 4). These ﬁndings were
not affected by the presence of a small proportion of individuals
of Asian origin (PGC-SCZ2-Eur: rg = 0.18 (s.e. = 0.06), P= 0.004,
Supplementary Table 4). Importantly, other PGC adult-onset
disorders, such as MDD and BIP, showed no correlations
with SCDC scores (Age 17: MDD-rg =−0.05 (s.e. = 0.11), P= 0.65
and BIP-rg = 0.04 (s.e. = 0.08), P= 0.62, Supplementary Table 4)
suggesting that ﬁndings are speciﬁc to schizophrenia.
Note that LD-score correlations between schizophrenia and ASD
(rg = 0.20 (s.e. = 0.05), P= 0.00011) were modest, compared with
considerably stronger links between schizophrenia and other
adult-onset disorders (for example, BIP-rg = 0.76 (s.e. = 0.04),
P= 6.5 × 10− 70, Supplementary Table 5), as previously reported.20
For comparison, we also analysed trait-disorder overlap using
LD score correlation without constraining intercepts
(Supplementary Table 4). In the presence of genetic links,
unconstrained rg-point estimates were, overall, in close corre-
spondence with constrained estimates, but had wider standard
errors.
Polygenic scores for risk-increasing alleles predicting social
communication difﬁculties
To provide an absolute measure of shared genetic inﬂuences
between traits and clinically recognised conditions, we assessed
the phenotypic variance in rank-transformed social communica-
tion difﬁculties due to risk-increasing alleles using polygenic
scoring43,44 (Table 1). Alleles more common in ASD cases than in
pseudo-controls were only associated with variation in SCDC
scores at 8 years (PGC-ASD: adjusted R2max = 0.13%, Pmin = 0.0042,
Figure 2a, Supplementary Table 6). In contrast, alleles more often
present in schizophrenia cases than controls explained predominantly
variation in social communication difﬁculties at 17 years, based on
risk alleles in both PGC-SCZ subsamples (PGC-SCZ1: adjusted
R2max = 0.26%, Pmin = 0.00058; PGC-SCZ2i: adjusted R
2
max = 0.19%,
Pmin = 0.0028; Supplementary Table 7) and the combined PGC-
SCZ2 sample (adjusted R2max = 0.43%, Pmin = 0.000012, Figure 2b,
Supplementary Table 6). Excluding ALSPAC children with a clinical
ASD diagnosis had little inﬂuence on the reported changes in
genetic effect (Supplementary Table 8). Importantly, adjustment of
ASD-PGS and schizophrenia-PGS for each other did not affect the
nature of these ﬁndings, suggesting the independence of ASD-
and schizophrenia-related polygenic inﬂuences (Supplementary
Table 6).
To assess developmental trends in common genetic trait-
disorder overlap, we modelled the effect of ASD-PGS and
schizophrenia-PGS on untransformed SCDC scores longitudinally.
Applying a mixed Poisson model, we found evidence for
age-speciﬁc changes in genetic effects for both ASD-PGS and
schizophrenia-PGS (Supplementary Table 9). For example, at
PTo0.05 (Figure 3), a threshold shown to predict schizophrenia
case-ness in independent samples,13 the effect of ASD-PGS
decreased with progressing age of the trait (ASD-PGS × SCDC-
age: Beta =− 0.0031 (s.e. = 0.0014), P= 0.019, 95%-bootstrapped
conﬁdence interval: − 0.0057 to − 0.00035), while the effect of
schizophrenia-PGS increased (schizophrenia-PGS x SCDC-age:
Beta = 0.0029 (s.e. = 0.0014), P= 0.030, 95%-bootstrapped conﬁ-
dence-interval: 0.00047 to 0.0054). Consistent with the ﬁndings for
rank-transformed scores, ASD-related polygenic inﬂuences on
SCDC score counts were strongest during childhood (age 8: Beta =
0.047 (s.e. = 0.017), P= 0.0056; age 17: Beta = 0.019 (s.e. = 0.018),
P= 0.29), while schizophrenia-related polygenic effects were more
pronounced during later adolescence (age 8: Beta = 0.046
(s.e. = 0.017), P= 0.0080; age 17: Beta = 0.072 (s.e. = 0.018),
Table 2. LD-score regression and GCTA results for SCDC scores in ALSPAC
SCDC score LD score regression GCTAa
Unconstrainedb Constrainedc λGC Mean χ2 N h2(SE)a Nd
Intercept(SE) h2(SE)
8 y 0.992 (0.0067) 0.19 (0.06) 1.023 1.022 5553 0.24 (0.07) 5137
11 y 1.000 (0.0065) 0.17 (0.07) 1.014 1.019 5462 0.17 (0.07) 5058
14 y 0.988 (0.0067) 0.08 (0.06) 1.005 1.009 5060 0.08 (0.07) 4735
17 y 1.009 (0.0070) 0.30 (0.11) 1.029 1.025 4175 0.45 (0.08) 3978
Abbreviations: ALSPAC, Avon Longitudinal study of Parents and Children; GCTA, genome-wide complex trait analysis; h2, SNP heritability; LD, linkage
disequilibrium; SCDC, Social Communication Disorder Checklist; y, age at assessment in years; λGC, Genomic inﬂation factor. aFindings correspond closely to
previously published estimates.27 bLD score regression using an unconstrained intercept. cLD score regression constraining the intercept for the SNP-h2
estimation to one. dDifferences compared with the total sample N are due to the exclusion of individuals with a relatedness of ≥ 2.5%.
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P= 0.000056). Similar developmental changes in genetic overlap
were also found for other PGS thresholds (Supplementary Table 9).
Attrition in ALSPAC
Analyses of SCDC-missingness in ALSPAC were carried out to
investigate potential sources of bias (Supplementary Table 10).
Using for simplicity a PGS threshold of PTo0.05, there was little
evidence for a relationship between sample-dropout and ASD-
PGS, especially after adjustment for maternal educational level
(age 8: odds ratio = 0.99 (s.e. = 0.03), P= 0.82), although there was
support for an association with schizophrenia-PGS (age 17: odds
ratio = 1.10 (s.e. = 0.03), P= 0.000050), consistent with previous
studies.52
DISCUSSION
This study provided evidence for shared common genetic overlap
between social communication difﬁculties and both ASD and
schizophrenia, but does not imply a shared genetic susceptibility
between these clinical conditions. Instead, we identiﬁed distinct
patterns in genetic trait-disorder relationships, largely consistent
with the onset of clinical symptoms. Genetic links were driven by
independent polygenetic inﬂuences and showed opposite trends
in magnitude with progressing age of the population-based trait,
as supported by longitudinal analyses.
Genetic overlap with ASD was strongest for social communica-
tion difﬁculties during middle childhood (rg ~ 33%), in line with
recent cross-sectional studies,25 while those with schizophrenia
was strongest for social communication difﬁculties during later
*
*
****
********
**
0.000
0.001
0.002
0.003
0.004
0.005
8 11 14 17
SCDC age (years) SCDC age (years)
A
dj
us
te
d 
R
2  
(A
S
D
-P
G
S
)
A
dj
us
te
d 
R
2  
(S
C
Z-
P
G
S
)
PGS bin
**
****
****
**
**
**
*
**
**
*
*****
**
***
******
***
************
0.000
0.001
0.002
0.003
0.004
0.005
8 11 14 17
PGS bin
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scores were constructed in ALSPAC based on the largest publicly available samples for ASD (PGC-ASD) and schizophrenia (PGC-SCZ2) as a
training set, and then Z-standardised. The proportion of explained phenotypic variance in rank-transformed SCDC scores (adjusted regression
R2) is displayed cross-sectionally at 8, 11, 14 and 17 years and given with respect to ASD-PGS (a) and schizophrenia-PGS (b). Nine different
P-value thresholds PT for selecting risk alleles (PGS bins) in clinical samples are displayed. Starred P-values indicate the strength of the
association (*P⩽ 0.05, **P⩽ 0.01). ALSPAC, Avon Longitudinal study of Parents and Children; ASD, autism spectrum disorder; PGC-ASD, ASD
collection of the PGC; PGC, Psychiatric Genomics Consortium; PGC-SCZ2, Samples of the second PGC mega-analysis of SCZ; PGS, polygenic
scores; PGS bin, Z-standardised polygenic scores according to threshold PT; SCDC, Social Communication Disorder Checklist; SCZ,
schizophrenia.
*
**
*
−0.3
0.0
0.3
0.6
8 11 14 17
SCDC age (years)
r g
 (A
S
D
)
** * **
*
−0.3
0.0
0.3
0.6
8 11 14 17
SCDC age (years)
r g
 (S
C
Z)
iPSYCH ASD
PGC ASD PGC SCZ2*
PGC SCZ1
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sectionally using LD-score correlation analysis20 and are shown with their standard errors (shaded). Standard error distributions for SCDC
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adolescence (rg ~ 18%). Complementary estimates were provided
by polygenic scoring analyses. Up to 0.13% phenotypic variation
in social communication difﬁculties could be explained by ASD
risk-increasing alleles during childhood and up to 0.43%
phenotypic variation by schizophrenia risk-increasing alleles
during later adolescence, independently of each other. The
genetic overlap with social communication difﬁculties during
later adolescence was not observed for other adult-onset
disorders, such as BIP, despite their strong genetic links with
psychosis,12 making unspeciﬁc age-related inﬂuences unlikely.
Thus, our ﬁndings suggest that social communication impairments
are part of the genetically inﬂuenced phenotypic spectrum of
schizophrenia.
Changes in genetic overlap over time need to be viewed within
the context of cohort-speciﬁc sampling properties and clinical
sample power. For instance, it is possible that the genetic overlap
between schizophrenia and social communication difﬁculties has
been underestimated, as SCDC-missingness, and more generally
study non-participation,52 has been related to common genetic
risk for schizophrenia. In contrast, there was little evidence for a
link between SCDC missingness and common ASD risk. In
addition, mother-report of social communication difﬁculties may
have contributed to enhanced variance sharing among
population-based traits, and thus underestimated the true
variation in child genetic effects. Finally, the studied clinical
discovery sets differed in their inherent power. For example, the
power44 of ASD-PGS (PGC-ASD ~ 5000 trios) was only 0.58
compared with 0.99 for schizophrenia-PGS (PGC-SCZ2,
N~ 80 000), assuming a liability-scale SNP-h2 of 0.23 for ASD and
0.25 for schizophrenia, a disease prevalence of 0.01, a type-I-error
rate of 0.05 and a population-based target sample of 5000
individuals. Under attrition, such as a decrease of ~ 1000 ALSPAC
participants during later adolescence, the power of ASD-PGS
would further drop (to 0.49), while the power of schizophrenia-
PGS remains largely unaffected (0.99). Longitudinal analyses,
adjusting for differences in population-based sample numbers
across time through bootstrapping, suggested, however, that the
observed developmental changes in polygenic risk effects are
robust, even in the presence of sample dropout.
Our results have direct relevance for the deﬁnition of RDoC21
within a developmental context. The lack of support for shared
polygenic effects between ASD and schizophrenia, with respect to
social communication impairments, is in agreement with recent
studies. Molecular analyses of PGC samples reported modest
correlations between ASD and schizophrenia20,29 (rg ~ 0.20),
conﬁrmed within this study, and twin research suggested little
genetic overlap between autistic traits and psychotic
experiences.53 The absence of shared aetiological factors strength-
ens furthermore positions suggesting that the exact nature of
social deﬁcits implicated within ASD and schizophrenia differs
from each other.54 Here we show that common genetic variation
underlying complex disorders can be dissected through temporal
changes in the genetic architecture of behavioural symptoms that
are shared between disorders. Thus, a developmental analysis of
genetic relationships between population-based and clinical
samples can be informative with regard to the dimensional
nature of psychiatric illness without discarding the aetiology of
different disorders, a concern often raised with respect to RDoC.21
The identiﬁcation of distinct patterns in common genetic
overlap between social communication difﬁculties and psychiatric
illness is consistent with the presence of multiple distinct genetic
inﬂuences contributing to variation in social communication
behaviour during development. While genetic factors underlying
SCDC scores across ~ 3-year intervals are stable and shared by at
least 80%, only ~ 50% of common genetic inﬂuences are shared
across 10 years intervals.27 This may suggest developmental (but
not rapid) changes in the phenotype capture by the SCDC with
progressing age. For example, it is possible that the behavioural
phenotypes inﬂuencing SCDC scores at age 8 or 11 years are, in
terms of average composition, different from those inﬂuencing
the scale at age 17. Social communication abilities comprise many
components, such as social interaction, social cognition, pragmatic
and language processing skills (http://www.asha.org/), some of
which will vary during child and adolescent development,
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Figure 3. Developmental changes in genetic effects of polygenic scores for (a) clinical ASD and (b) clinical schizophrenia on SCDC scores.
Polygenic scores (PGS) were constructed in ALSPAC based on the largest publicly available samples for ASD (PGC-ASD) and schizophrenia
(PGC-SCZ2) as a training set, and then Z-standardised. A P-value threshold of PT o0.05 for selecting risk alleles in clinical samples is displayed.
Using a mixed Poisson regression framework, longitudinal measures of untransformed SCDC score counts were regressed on ASD-PGS and
schizophrenia-PGS simultaneously allowing for changes in genetic effects over time. Repeatedly assessed SCDC score counts in ALSPAC were
available at 8, 11, 14 and 17 years of age with individual ages ranging between 7 to 18 years. Genetic effects for ASD-PGS (a) and their 95%
conﬁdence intervals (shaded) as well as schizophrenia-PGS (b) and their 95% conﬁdence intervals (shaded) were estimated across
development, and show the increase in SCDC log counts per standard deviation in PGS score. A dotted line indicates the P-value of the
genetic effect. ALSPAC, Avon Longitudinal study of Parents and Children; ASD, autism spectrum disorder; PGC-ASD, ASD collection of the PGC;
PGC, Psychiatric Genomics Consortium; PGC-SCZ2, Samples of the second PGC mega-analysis of SCZ; SCDC, Social Communication Disorder
Checklist; SCZ, schizophrenia.
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including changes in the social-cognitive understanding of
friendship and peer interaction.55 One might envisage that these
phenotypic changes reﬂect distinct genetic factors driving
different stages of postnatal brain development.56 In addition,
social communication difﬁculties have been linked to behavioural
problems.57 Note that the SCDC has a high sensitivity but a lower
speciﬁcity in discriminating ASD from the non-ASD patients in the
presence of other clinical disorders.26 Thus, the SCDC is likely to
capture multiple behavioural and cognitive dimensions related to
social communication problems during the course of child and
adolescent development, spanning around 10 years, which give
rise to distinct patterns in trait-disorder overlap. This poses
questions on the nature of genetic inﬂuences affecting variation in
social communication impairments across development that will
require exploration with longitudinal genome-wide approaches
and biological network analyses.
CONCLUSIONS
Social communication difﬁculties are phenotypically shared with
both ASD and schizophrenia and show common genetic overlap
with both disorders. These polygenic links manifest, however, as
distinct developmental proﬁles and do not imply a shared genetic
susceptibility between these clinical conditions.
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